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To enhance the penetration of oligonucleotide (“oligo’) into cells, the &go was combined with the hydrophobic undccyl residue. Using the ‘DNA- 
synthesator’, we synthesized oligo, complementary to the loop-forming site of the RNA, encoding polymerase 3 of the iniluenza virus (type A), 
and comb&d it with the undecyl residue added to the 5’ terminal phosphate group. It was found that the modified oligo effectively suppresses 
the influenza AIPR8j34 (HINI) virus reproduction and inhibits the synthesis of virus-specific proteins in MDCK cells. Under the same conditions, 
the non-modified antisense otigo and modified nonsense oligo did not affect the virus development. 
Antisense; ~~gonuc~eotide~ Influenza; Virus; ~nh~b~ti~n~ Translation 
I _ INTRODUCTION 
Modulation of the ability of biopolymers to penetrate 
biological membranes seems to have become one of the 
key problems of modern biochemistry and medicine. 
The difficulties connected with the passing across the 
membrane barrier limit considerably the possibilities of 
drug targeting fl], genetic transfo~ation of cells f2], 
regulation of intracellular processes by exogenous pro- 
tein factors [3] and nucleic acids 141. 
The method for imparting transmembrane properties 
to water-soluble proteins, based on their covalent modi- 
fication with hydrophobic ‘anchor’ groups (e.g. fatty 
acid residues) has been developed recently 1%71. The 
modified protein molecules acquire the ability to trans- 
locate across lipid membranes [5] and to penetrate into 
intact cells [6,7]. 
The principle of artificial hydrophobization [5J per- 
mitted us to suggest a method for the suppression of 
virus repr~uction in the cells: fatty acylated antiviral 
antibodies considerably inhibit the virus development in 
cells, presumably, disturbing the proper assemblage 
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MDCK cells were kindly presented by the Laboratory of CelI Cul- 
tures (Institute of V&fogy, USSR Academy of Medical Sciences). 
Cells were grown as a monolayer stationary ctrlture in 199 medium, 
containing 10 mM Hepes, 0.075% sodium bicarbonate, 10% fetal 
calf serum and 200 /rg/ml gentamycin. 
Abbreviatbns: Aerosol OT, sodium bis(2-ethylhexyl)suIfosuccinate; Influenza virus (strain A/PR8/34 (HlNl)) was passed in the allan- 
Hepes, N-(2-hydroxyethyl)piperazine-N’-2-ethanesulfonic acid toic cavity of g-day-old fertilized eggs at low multiplicity. The allan- 
sodium saft; Mes, 2-~~-morpho~~no~hanesuIfonic acid; PFU, pla- toic fluid was clarified at 6000 x g x t5 min. stored at --WC, and 
que forming units then used as an inocuIum in virus reproduction experiments. 
and budding of infective virus particles [S,$]. However, 
it is likely that the hydroph~bized antibodies do not af- 
fect the translation of the virus-specific proteins in the 
infected cells (in preparation). 
In order to block the synthesis of virus components in 
a cell it is reasonable to use the antisense inhibition of 
this process by short complementary oligo~ucleotides 
coligos*), which are regarded now as one of the most 
promising tools for the regulation of transcription and 
translation [4,10]. However, the application af oligos is 
considerably limited by the low efficiency of their pene- 
tration into intact cells. 
For enhancing the oligos action on cells we suggested 
IIll that they should he terminally modified with hy- 
drophobic groups. In the present work we have studied 
the effect of antisense oligo, modified at the 5 ‘-end with 
fatty radicals, on the reproduction of the influenza 
A/PR8/34 (HlNl) virus and synthesis of the virus- 
specific proteins in MDCK cells. 
2. MATERIALS AND METHODS 
2.1. Ceils and viruses 
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2.2. Oiigo synthesis 
The oligos were synthesized with the DNA-synthesator (Applied 
Biosystems, Model 380 B-02) using 2cyanoethylphosphoramidite 
building blocks (American Bionetics) with a cycle modified for a 
3 mm01 scale 1121. 
2.3. Introduction of undecyl radicals during oligo synthesis 
n-Undecyl-2-cyanoethyldiisopropylamidophosphirte was synthesiz- 
ed from undecanol by a modified 3-stage procedure with the applica- 
tion of 2-cyanoethyl-N&N :N ‘-tetraisopropylp~osphorodiamidite 
1131. 
This reagent was introduced at the 5 ‘-end of the growing chain dur- 
ing the oligo synthesis with the DNA-synthesator. This last stage was 
repeated twice without deblocking and capping. 
The modified oligos were precipitated in LiClOa-acetone and were 
analyzed under denaturing conditions (7 M urea) by PAGE. 
2.4. OEgo rnod~~catio~ in reversed micelles 
The oligos, cont~ning a 5 ‘-end phosphate group, were obtained by 
the addition of bis(2-cyanoethyl)diisopropylamidophosphine 1141 at 
the last stage of the oligo synthesis with the DNA-synthesator. 
The procedure of modification of these oligos with undecyl radicals 
in the system of Aerosol OT reversed micelles was analogous to the 
method of protein modification described earlier [15,16]. Mes buffer 
(X0$, pH 5.5), containing 10 nmol of oligo, were solubilized in 
8.5 ml of 0.3 M Aerosol OT (Merck) solution in octane. 220 mg of 
dry 1-cyclohexyl-3-(2-morphoiinoethyl) carbodiimide (Sigma) were 
added to the obtained optically transparent system of reversed 
micelles. After 30 min incubation, 50 ~1 of undecanol (Sigma) were 
solubilized in the reaction system. 
The system obtained was incubated for 10 h at room temperature 
and then the modified oligo was precipitated by 30 ml of cold (OOC) 
acetone. The precipitate formed was then removed by centrifugation 
and thoroughly washed 2 times with 30 ml cold acetone. The residual 
acetone was removed using a rotor evaporator. 
The modified oligos were analyzed by PAGE as described above. 
2.5. Virus reproduction 
The monolayers of permissive MDCK cells were infected with in- 
fluenza virus (strain A/PR8/34) at 20-100 plaques per dish multiplici- 
ties. After adsorption (60 min, 37’C) the virus inoculums were re- 
moved, the cells were washed and covered by the standard agar over- 
lay with trypsin f17], containing different concentrations of oligos. 
Three days after infection the cells were stained, the number of pla- 
ques was counted and their size was estimated. 
2.6. Synthesis of virus-specific proteins 
The MDCK cells were infected with influenza A/PR8/34 virus at 
high multiplicity (10 PFUlcell). After removing the virus inoculum 
and washing the cells, the equimolar mixture of the “C-labe11ed 
(5 &i/ml) amino acids (UVVVR, Czechoslovakia) in 199 medium, 
containing 100 PM of oligos, was added to the infected cells. Fifteen 
hours after the infection, cells were collected, washed (2 times with 
cold 7% trichloroacetic acid and 2 times with 96% ethanol) and lysed 
with the buffer for electrophoresis. The cellular lysates were analyzed 
by PAGE. The gels were fixed, stained and dried and the autoradio- 
graphs were made using R-Film. 
3. RESULTS 
3.1. O&o synthesis and modification 
Two oligos were synthesized using the standard tech- 
nique, namely, 
TTGACGAAATT (1) 
which is complementary to the loop-forming site of the 
RNA, encoding polymerase 3 of the influenza virus 
[ 181; and a ‘nonsense’ oligo 
GGGTGTTAGAG (IL) 
which does not interact with influenza virus RNAs. 
For the introduction of hydrophobic radicals at the 
5’-ends of these oligos, two different methods were 
developed. 
Fig. 1, Plaque formation in the monolayer of MDCK cells infected by influenza AfPR8/34 virus [l?] in the media cont~ning: (A) no oligos; (B) 
10 FM, (C) 50 pM, (D) 100 aM, (E) 200 pM of modified oligo (I); (F) 200 ,uM of non-modified oligo (I}. 
328 
Volume 259, number 2 FEBSLETTERS January 1990 
According to one of them the n-undecanol derivative 
n-undecyl-2cyanoethyldiisopropylamidophosphine 
, N(iW2 
n-cllH230-P \ 
WHWN 
was introduced at the 5 ‘-ends of the growing chains at 
the last stage of the oligo synthesis with the DNA- 
synthesator. By the PAGE data the yield of the undecyl- 
modified oligos at this last stage was 90-95%. 
The second method, which is most valuable for the 
hydrophobization of already formed (e.g. natural) 
oligos, is based on the use of the system of the surfac- 
tant reversed micelles in the organic solvent (Aerosol 
OT in octane) [19] as a medium for the oligo modifica- 
tion. Being solubilized in such a system the polar oligo 
molecules are entrapped in the inner water cavity of re- 
versed micelles. The modifying water-insoluble reagent 
is localized not only in the bulk phase of the organic sol- 
vent, but can be incorporated in the reversed micelle, 
thus coming into contact with the oligo groups to be 
modified [l&16]. 
We applied this method for the attachment of 
undecanol residues to the oligos, containing 5 ‘-end 
phosphate groups, activated by a standard carbodi- 
imide procedure. In this case, the yield of the obtained 
undecyl-modified oligos was 60-70%. 
P 
NP 
HA 
NS 
Fig.2. Protein synthesis in the (l-3) infected and (4) non-infected 
MDCK cells. The cells were incubated in the media, containing: (1,4) 
no oligos; 100 PM of (2) non-modified and (3) modified oligo (I). Ar- 
rows indicate the influenza virus polymerases (P), nucleoprotein 
(NP), hemagglutinin (HA) and non-structured (NS) proteins [20]. 
3.2. Oligos affect virus reproduction 
The effect of the undecyl-modified oligos on the re- 
production of influenza A/PR8/34 virus in permissive 
MDCK cells was investigated using the plaque-assay 
method. 
As can be seen in fig.1, the modified oligo (I) con- 
siderably suppressed the development of the virus infec- 
tion (the number and the size of the plaques), whereas 
the non-modified oligo (I) did not produce such an ef- 
fect at the same concentrations. 
The modified nonsense oligo (II) did not affect the 
virus reproduction, i.e. the observed effect resulted 
from the specific interaction of antisense oligo (I) with 
the corresponding site of viral RNA (not shown in the 
figure). 
Fig.2 illustrates the results of the experiment studying 
the protein synthesis in high-multiplicity infected cells. 
Four major bands, corresponding to the virus-specific 
proteins [20], are observed at the autoradiograph of the 
infected MDCK cells lysate (lane 1). The treatment of 
these cells with non-modified oligo (I) practically did 
not affect the synthesis of viral proteins (lane 2). 
On the contrary, the addition of the modified oligo 
(I) to the infected cells led to a considerable inhibition 
of the synthesis of these proteins. In this case (lane 3) 
the viral polymerases are undetectable and the bands of 
other viral proteins are at least strongly diminished. In 
other words, the observed protein pattern of the cell 
lysate is almost similar to that, observed for non- 
infected MDCK cells (lane 4). 
The nonsense oligo (II) (both the non-modified and 
the modified species) did not affect the synthesis of 
virus-specific proteins. 
4. CONCLUDING REMARKS 
The data obtained indicate that the observed inhibi- 
tion of the influenza virus reproduction and synthesis 
of the virus-specific proteins in MDCK cells treated 
with undecyl-modified oligo (I) results from the intra- 
cellular binding of this oligo to the complementary 
loop-forming site of the viral RNA, which presumably 
is responsible for the RNA-protein interaction. 
Convincing evidence was obtained that the covalent 
attachment of fatty radicals to the oligo molecule con- 
siderably enhances its action on the cells. If compared 
with other methods of enhancing the oligos’ penetra- 
tion into the cell, and increasing their activity [10,21] 
the method suggested in this work seems to become very 
promising in drug design, since the fatty modified 
oligos are produced with a high yield with application 
of simple and standard procedures, e.g. directly in the 
DNA-synthesator. 
The key problem of oligos targeting to the infected 
cells must be solved for their successful medical applica- 
tion. 
It has been recently demonstrated [22] that the effi- 
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ciency of the DNA penetration into the cells can be 
greatly increased through its incorporation into the sol- 
uble interpolyelectrolyte complexes (IPC) with carbo- 
chain polycations. Such complexes form spontaneously 
on mixing the nucleic acid and polycation solutions. Be- 
ing entrapped in IPS, the oligo molecule acquires resist- 
ance against cleavage with nucleases, p~i~ul~ly in 
blood serum (in preparation). A target-recognizing 
molecule (e.g. the antibody against virus antigen) can 
bind covalently to the IPC-forming polycation. This 
might be a way to address the oligo molecules, packed 
in IPC particles, into a certain target cell. 
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